DrugCite
Search

ESTROPIPATE

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Estropipate Adverse Events Reported to the FDA Over Time

How are Estropipate adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Estropipate, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Estropipate is flagged as the suspect drug causing the adverse event.

Most Common Estropipate Adverse Events Reported to the FDA

What are the most common Estropipate adverse events reported to the FDA?

Breast Cancer Female
90 (22.44%)
Breast Cancer
69 (17.21%)
Breast Cancer Metastatic
9 (2.24%)
Drug Ineffective
9 (2.24%)
Pain
8 (2%)
Weight Decreased
7 (1.75%)
Anxiety
6 (1.5%)
Hypersensitivity
5 (1.25%)
Malaise
5 (1.25%)
Muscle Spasms
5 (1.25%)
Nausea
5 (1.25%)
Show More Show More
Affect Lability
4 (1%)
Emotional Disorder
4 (1%)
Headache
4 (1%)
Marital Problem
4 (1%)
Night Sweats
4 (1%)
Rash Erythematous
4 (1%)
Rash Pruritic
4 (1%)
Abdominal Pain
3 (.75%)
Body Height Decreased
3 (.75%)
Breast Operation
3 (.75%)
Breast Tenderness
3 (.75%)
Cough
3 (.75%)
Dyspnoea
3 (.75%)
Hyperhidrosis
3 (.75%)
Hypersomnia
3 (.75%)
Increased Upper Airway Secretion
3 (.75%)
Influenza
3 (.75%)
Scar
3 (.75%)
Terminal Insomnia
3 (.75%)
Abdominal Discomfort
2 (.5%)
Abdominal Pain Lower
2 (.5%)
Arterial Thrombosis Limb
2 (.5%)
Blood Cholesterol Increased
2 (.5%)
Breast Cancer In Situ
2 (.5%)
Breast Cancer Stage Iii
2 (.5%)
Breast Cyst
2 (.5%)
Dizziness
2 (.5%)
Drug Effect Decreased
2 (.5%)
Drug Hypersensitivity
2 (.5%)
Drug Intolerance
2 (.5%)
Emotional Distress
2 (.5%)
Fall
2 (.5%)
Feeling Abnormal
2 (.5%)
Hot Flush
2 (.5%)
Hypertension
2 (.5%)
Hypothyroidism
2 (.5%)
Insomnia
2 (.5%)
Lung Disorder
2 (.5%)
Menopausal Symptoms
2 (.5%)
Metastases To Lymph Nodes
2 (.5%)
Mood Swings
2 (.5%)
Oestrogen Receptor Assay Positive
2 (.5%)
Ovarian Cancer
2 (.5%)
Paraesthesia
2 (.5%)
Peripheral Coldness
2 (.5%)
Product Substitution Issue
2 (.5%)
Progesterone Receptor Assay Positiv...
2 (.5%)
Pruritus
2 (.5%)
Scleroderma
2 (.5%)
Shock
2 (.5%)
Swelling
2 (.5%)
Tremor
2 (.5%)
Weight Increased
2 (.5%)
Abdominal Distension
1 (.25%)
Abdominal Pain Upper
1 (.25%)
Abortion Spontaneous
1 (.25%)
Alopecia
1 (.25%)
Anaemia
1 (.25%)
Anaphylactic Reaction
1 (.25%)
Angiopathy
1 (.25%)
Asthenia
1 (.25%)
Blood Glucose Increased
1 (.25%)
Body Temperature Increased
1 (.25%)
Breast Calcifications
1 (.25%)
Breast Enlargement
1 (.25%)
Breast Mass
1 (.25%)
Breast Pain
1 (.25%)
Cardiac Disorder
1 (.25%)
Confusional State
1 (.25%)
Delirium
1 (.25%)
Drug Administration Error
1 (.25%)
Drug Exposure During Pregnancy
1 (.25%)
Eating Disorder
1 (.25%)
Electrocardiogram Qt Prolonged
1 (.25%)
Erythema
1 (.25%)
Feeling Hot
1 (.25%)
Fibrocystic Breast Disease
1 (.25%)
Food Interaction
1 (.25%)
Gastrointestinal Haemorrhage
1 (.25%)
Hair Texture Abnormal
1 (.25%)
Hepatic Enzyme Increased
1 (.25%)
Herpes Zoster
1 (.25%)
Hypokalaemia
1 (.25%)
Injury
1 (.25%)
Irritability
1 (.25%)
Lobar Pneumonia
1 (.25%)
Metastases To Peripheral Vascular S...
1 (.25%)
Metastasis
1 (.25%)
Mouth Ulceration
1 (.25%)
Muscle Twitching
1 (.25%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Estropipate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Estropipate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Estropipate

What are the most common Estropipate adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Estropipate, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Estropipate is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Estropipate According to Those Reporting Adverse Events

Why are people taking Estropipate, according to those reporting adverse events to the FDA?

Hormone Replacement Therapy
220
Hormone Therapy
28
Menopausal Symptoms
27
Menopause
12
Drug Use For Unknown Indication
10
Postmenopause
8
Show More Show More
Product Used For Unknown Indication
8
Emotional Disorder
4
Hysterectomy
4
Oestrogen Replacement Therapy
4
Hot Flush
4
Hormone Level Abnormal
3
Night Sweats
3
Osteoporosis
2
Blood Oestrogen
2
Amnesia
2
Crying
1
Mood Swings
1
Oestrogen Therapy
1
Oral Contraception
1
Hyperhidrosis
1
Routine Health Maintenance
1
Insomnia
1
Electrocardiogram Abnormal
1
Urinary Incontinence
1
Ill-defined Disorder
1

Drug Labels

LabelLabelerEffective
EstropipateMylan Pharmaceuticals Inc.28-SEP-09
EstropipatePhysicians Total Care, Inc.14-MAR-12
EstropipateWatson Laboratories, Inc.30-JUL-12
EstropipateBarr Laboratories Inc.16-AUG-12

Estropipate Case Reports

What Estropipate safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Estropipate. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Estropipate.